ODAM - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pGFP-V-RS |
ODAM - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pGFP-V-RS |
DUSP10 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pGFP-V-RS |
HLA-DRA - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pGFP-V-RS |
WEE1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRFP-C-RS |
DLGAP5 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
PSMF1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
FZD1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
FZD7 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
TFDP1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
UBE2M (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
TSC1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Aifm1 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Spns2 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Mvk (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
MYH9 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRFP-C-RS |